[ Price : $8.95]
FDA tells Neos Therapeutics that it has identified deficiencies that preclude discussion of labeling and postmarketing requirement...[ Price : $8.95]
FDA requests additional information from Zogenix about the companys proposed Phase 3 program for ZX008, indicated for treating Dra...[ Price : $8.95]
In a sign that it may be backing down from its position against truthful and non-misleading off-label promotion, FDA quietly remov...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Gentell and St. Jude Medical.[ Price : $8.95]
FDA posts a draft guidance on Manufacturing Site Change Supplements: Content and Submission that explains the agencys current thin...[ Price : $8.95]
Federal Register Notice: FDA plans a meeting 11/8 on Office of Womens Health Update on Strategic Priorities and Initiatives of int...[ Price : $8.95]
Indias Economic Times newspaper says that FDA inspectors found several violations in an inspection at Ciplas Indore manufacturing ...[ Price : $8.95]
Two researchers writing in JAMA Internal Medicine say FDA since 2008 has been approving a higher percentage than in the past of ca...